Gene-engineering expressing IL-15 136, IL-7 and CCL19 137, and IL-4/21 138 has also been explored to boost anti-tumor activities through promoting proliferation, survival, activation, and stem cell memory subset of CAR-T cells and endogenous T cells. The gene discussed is IL7; the disease is neoplasm.